drugset / Trial / NCT02302092

An Efficacy and Safety of Flomoxef Versus Cefepime in the Treatment of Participants With Urinary Tract Infections

NCT02302092

Phase 3 Terminated 13 enrolled Takeda
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to compare the effectiveness of antibiotic flomoxef with cefepime for the treatment of complicated urinary tract infections (cUTIs) in Russian adults.

Timeline

Start
2015-12-01
Primary completion
2016-02-02
Completion
2016-12-15

Drugs

EvaluationDrugModalityDoseRoute
Comparator Cefepime Small molecule 1 g Intravenous
Subject Flomoxef Small molecule 2 g Intravenous